Let’s make 9/22 International CML Awareness Day!

The CML Advocates Network, a worldwide network of CML patient associations, is suggesting the proclamation of 22 September (9/22) as International CML Awareness Day. The date represents the genetic change of Chromosomes 9 and 22 which causes CML. The iCMLf welcomes the initiative, and calls on all physicians worldwide to actively support it.

iCMLf thanks all its contributors, calls for donations

The activities of the iCMLf are supporting healthcare professionals to access knowledge, skills and tools in order to achieve the best possible outcomes, especially in regions where this assistance is most needed. As a charitable foundation, this is only possible through unrestricted grants and donations. We are grateful for the first private donations that have reached us. Please donate, we appreciate your support!

In addition, for 2011, the iCMLf is very pleased to recognise Novartis Oncology and Bristol Myers-Squibb as a Premium Sponsors, Ariad as Major Sponsor, and The Max Foundation for sponsoring the Virtual Education Program. We are grateful for all support that enables us to support better care for CML patients.

New interactive forum for clinicians discussing difficult CML cases

To share and enhance best practice management of CML the iCMLf has opened a discussion forum where experts and interested clinicians can discuss difficult, or interesting CML patient cases. Clinicians submit a brief history of the patient and the case for discussion (no more than 200 words) to the iCMLf web-site coordinator, This e-mail address is being protected from spambots. You need JavaScript enabled to view it . Each case accepted will be published in the discussion forum with a brief response. Further comments, questions and discussion are invited.

Press Release: ASH Annual Meeting, Orlando - 4th December 2010 - Download as PDF

The iCMLf and The Max Foundation Launch new Virtual Education Program for Physicians from Emerging Regions

On 4 December 2010 the International Chronic Myeloid Leukemia Foundation (iCMLf) in partnership with The Max Foundation launched the iCMLf Virtual Education Program for clinicians from emerging regions. In this innovative format, leading haematologists provide e-learning tutorials about best practices for the management of patients with Chronic Myeloid Leukemia (CML), taking into consideration the specific challenges in these regions. This program progresses the iCMLf's mission to improve the outcomes for patients with CML globally.